BDX
57
2
HAS
42
-2
L
58
2
GME
52
-2
EA
63
-2
APA
37
3
CL
59
-3
GLW
50
2
DFS
47
5
FSLR
32
-2
KMI
77
-4
NEM
55
2
AN
38
-2
ADBE
33
-4
CMG
43
-4
DVN
32
3
CMCSA
52
6
KMB
45
-2
CTAS
46
-3
MPC
44
-2
BDX
57
2
HAS
42
-2
L
58
2
GME
52
-2
EA
63
-2
APA
37
3
CL
59
-3
GLW
50
2
DFS
47
5
FSLR
32
-2
KMI
77
-4
NEM
55
2
AN
38
-2
ADBE
33
-4
CMG
43
-4
DVN
32
3
CMCSA
52
6
KMB
45
-2
CTAS
46
-3
MPC
44
-2
Financhill
Back

BridgeBio Pharma Stock Predictions

Your Data Made Them Billions-Now It's Your Turn to Profit

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.
Sell
46

BBIO
BridgeBio Pharma

Last Price:
$32.19
Seasonality Move:
-0.02%

7 Day Trial

ALL ACCESS PASS

$ 7

The Tariff-Proof Asset in Your Pocket

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

BridgeBio Pharma Stock Forecast

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 58.3% based on the past 5 years of stock performance.
  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%
  • Is BridgeBio Pharma Stock Undervalued?
    The current BridgeBio Pharma [BBIO] share price is $32.19. The Score for BBIO is 46, which is 8% below its historic median score of 50, and infers higher risk than normal.
  • BBIO is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.

Will BridgeBio Pharma Stock Go Up Next Year?

  • Over the next 52 weeks, BridgeBio Pharma has on average historically risen by 58.3% based on the past 5 years of stock performance.

BridgeBio Pharma Stock Rating

Sell
46
BridgeBio Pharma (BBIO) is a Sell

Is BridgeBio Pharma overpriced?

  • BridgeBio Pharma has risen higher in 4 of those 5 years over the subsequent 52-week period, corresponding to a historical accuracy of 80%

BridgeBio Pharma Stock Price History

Is BBIO stock going to rise?

  • Based on the share price being below its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bearish and BBIO is experiencing slight buying pressure.

Stock Information

Stock Info

Exchange:
NASDAQ
Country:
United States
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
bridgebio.com

52-Week Data

52-Week High:
39.47
52-Week Low:
21.62

Prediction Charts

Market Cap:
6.1B
Price in USD:
32.19
Volume:
1.9M
Beta:
1.10

Technical Analysis

SMA50:
33.29
SMA100:
29.63
SMA200:
27.97
52-Wk Change:
15.75%

Stock Predictions

  • Is BridgeBio Pharma stock public?
    Yes, BridgeBio Pharma is a publicly traded company.
  • What is the BridgeBio Pharma stock quote today?
    The BridgeBio Pharma stock price is 32.19 USD today.
  • How to buy BridgeBio Pharma stock online?
    You can buy BridgeBio Pharma shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Feb-26 34.73 33.45 35.01 33.04
Feb-27 33.45 34.25 35.02 33.36
Feb-28 33.80 34.90 34.99 33.45
Mar-3 34.54 33.01 35.00 32.32
Mar-4 32.72 33.56 33.92 31.69
Mar-5 33.77 34.98 35.20 33.57
Mar-6 32.50 32.23 33.45 31.69
Mar-7 32.12 31.57 32.64 31.22
Mar-11 31.38 32.34 32.66 31.34
Mar-12 32.39 32.59 33.19 32.39
Mar-13 32.37 32.31 32.82 31.85
Mar-14 32.59 32.97 33.45 32.42
Mar-17 32.98 33.01 33.44 32.33
Mar-18 31.81 32.19 32.65 31.50

BridgeBio Pharma Earnings

BridgeBio Pharma Earnings Report: Per Share BridgeBio Pharma Earnings Q1 Q2 Q3 and Q4 last year and next year.

BridgeBio Pharma Forecast Revenue Growth

BridgeBio Pharma Stock Analysis: Historical quarterly revenues per share for BridgeBio Pharma and historical quarterly revenue growth:

  • Analysts estimate an earnings decrease this quarter of $0.03 per share, a decrease next quarter of $0.05 per share, a decrease this year of $1.35 per share, and an increase next year of $0.57 per share.

* BridgeBio Pharma stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.